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Abstract
Background: Currently, larger domestic pigs are only animals widely used in vaccine evaluation and pathogenicity
study of classical swine fever virus (CSFV). This study was aimed to create an alternative animal experimental
infection model of CSFV.
Results: Twenty specific-pathogen-free Bama miniature pigs were randomly divided into two groups and rooms,
infected and non-infected, and the pigs in the infected group were inoculated intramuscularly with 10
4,1 0
5 or 10
6
TCID50 (median tissue culture infective dose) CSFV Shimen strain (n = 5 × 3) or left uninoculated to serve as in-
contact pigs (n = 3). The uninfected control pigs (n = 2) were housed in a separate room. Clinical signs, body
temperature, viraemia, tissue antigen distribution, pathological changes and seroconversion were monitored.
Clinical signs were observed as early as 2 days post-inoculation (dpi) in all infected pigs (though mild in contact
pigs), but not non-infected control pigs. All inoculated pigs showed viraemia by 6 dpi. The in-contact pigs showed
lower levels of viraemia. At 10 dpi, seroconversion was noted in five of the 15 inoculated pigs. All inoculated or
one in-contact pigs died by 15 dpi.
Conclusions: These results show that Bama miniature pigs support productive CSFV infection and display clinical
signs and pathological changes consistent with CSFV infections observed in larger domestic pigs.
Keywords: Bama miniature pigs, classical swine fever virus, infection model
Background
Classical swine fever (CSF) is caused by classical swine
fever virus (CSFV) and results in significant losses to the
pig industry worldwide. CSFV belongs to the Pestivirus
genus within the Flaviviridae family [1]. It is an envel-
oped virus containing a single-stranded, positive-sense
RNA encoding a 3,898 amino acid polyprotein, which
undergoes co- and post-translational processing by cel-
lular and viral proteases to yield 11-12 cleavage products
[2,3].
Pigs are the natural host of CSFV, and are used as
models for CSFV research. Therefore, vaccines against
CSF should be evaluated exclusively in pigs in preclini-
cal and clinical trials. A major challenge, however, is
that domestic pigs are large and difficult to handle; thus,
a convenient animal model is required for the study of
CSF and other swine diseases. Several minipig strains,
such as Göttingen, CLAWN, Yucatan, Lanyu, Bama,
Sinclair and Hanford, have been used as toxicological
and pharmacological models. Minipigs have also been
used as a model for experimental infections for some
pathogens including Escherichia coli [4], Streptococcus
suis [5], Schistosoma japonicum [6], and dengue virus
[7]. Chinese Bama miniature pigs are genetically stable,
highly inbred, and small (adult mean body weight, 40
kg) [8-10]. The animals are easy to handle compared to
larger domestic pigs. In addition, it is feasible to take
repeated samples of sufficient volume to enable vaccine
studies. This makes the breed an excellent model for
use in study on cardiovascular and gastrointestinal dis-
eases, Helicobacter pylori infection, renal disease, skin
pharmacology, and xenotransplantation [11,12]. The
small size of the animals makes them ideal an infection
model and an attractive alternative to larger domestic
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any medium, provided the original work is properly cited.pigs, especially for long-term trials. Recently, specific-
pathogen-free (SPF) Bama miniature pig populations
have been established in China as experimental animals
for medical and veterinary applications.
To the best of our knowledge, there are no published
reports on Bama miniature pigs experimentally infected
with CSFV. This study details the results of experiments
in which Bama miniature pigs were experimentally
infected with the highly virulent Shimen strain of CSFV.
Results
Clinical features of experimentally-infected Bama
miniature pigs
Previous studies showed that domestic pigs challenged
with 10
5 TCID50 CSFV Shimen strain exhibited severe
clinical signs typical of CSF [13]. Therefore, in the pre-
sent study, Bama miniature pigs were inoculated i.m.
with different doses of CSFV (10
4,1 0
5 or 10
6 TCID50).
The results showed that all pigs in groups A (infected
with 10
4 TCID50), B (10
5 TCID50), and C (10
6 TCID50)
showed clinical signs (fever, shivering and anorexia) at 2
(groups A and B) and 3 (group C) days post-inoculation
(dpi), accompanied by a significant increase in rectal
temperature. The clinical outcomes for each pig follow-
ing viral challenge are summarised in Table 1. The inci-
dence of fever was significantly higher in group A than
in group C (P < 0.05); however, no obvious difference
was observed between groups A and B. These early clin-
ical signs were followed by loss of appetite, lethargy,
stiffness of gait, reddening of the conjunctiva and loose
stools or diarrhoea. As the disease progressed the clini-
cal scores were > 6, and the pigs began to die at 13 dpi.
Notably, no reddening, haemorrhage, or petechiae were
observed in the three in-contact animals before 10 dpi.
These in-contact pigs initially displayed mild clinical
signs at 10 dpi. Surprisingly, the clinical scores were
very low prior to death. Death occurred from 9 dpi in
groups A, B, and C. At 15 dpi, the survival rates in
groups A, B, C, D and E were 0/5, 0/5, 0/5, 2/3 and 2/2,
respectively (Figure 1). The control pigs in group E
remained healthy throughout the trial.
Antibody responses to CSFV infection
At 7 dpi, no anti-CSFV antibodies were detectable in
any of the pigs. At 10 dpi, the pigs began to seroconvert:
one in group A (antibody blocking rate, 43.7%), one in
group B (45%) and two in group C (51.3% and 64%). At
15 dpi, one more pig in group B seroconverted (43.5%).
Viraemia and viral RNA distribution in the tissues of
experimentally infected pigs
Serum samples collected prior to inoculation and at 0, 1,
3, 7, 10 and 15 dpi and tissues collected at necropsy
were tested for viral RNA using the real-time RT-PCR
as described previously. Viral RNA was detected in the
serum of all pigs (except non-infected controls) at 3 dpi,
with the viral loads peaking between 7 to 10 dpi (Table
2). Animals inoculated with 10
6 TCID50 CSFV Shimen
strain developed early and severe clinical signs and
showed higher viral RNA loads (up to 10
6 copies/μL)
than the other inoculated animals. The in-contact pigs
developed fewer clinical signs and became viraemic 10
dpi. The viral RNA load was < 10
5 copies/μL( T a b l e2 ) .
The CSFV RNA load in the different tissues was also
examined. Generally, the viral load was higher in pigs
challenged with 10
4 TCID50 than in the other pigs.
Higher level viral RNA was detected in the lymph
nodes, tonsils, spleen, and lung than in the urinary blad-
der and stomach (Figure 2). The level of viral RNA in
the tissues of pigs challenged with 10
4 TCID50 CSFV
was significantly higher than that in pigs challenged
with 10
5 TCID50 or 10
6 TCID50 or in-contact pigs (P <
0.01). There was no difference between groups B, C and
D( F i g u r e2 ) .N ov i r a lR N Aw a sd e t e c t e di nt h et w o
uninfected control pigs.
Pathological and histopathological findings
Pigs died of infection were, subjected to pathological
and histopathological examination following standard
operational procedures, and any observed lesions
recorded. All the surviving pigs were euthanised at 15
dpi and also subjected to pathological and histopatholo-
gical examination. Inoculated pigs showed lesions typical
Table 1 Clinical outcome of the pigs following viral challenge.
Groups No. of animals with fever (≥ 40.5°C) No. of days to fever onset Fever frequency during the trial Survival rates
A 5/5 2 26/56 0/5
B 5/5 2 21/51 0/5
C 5/5 3 18/58 0/5
D 3/3 10 3/11 2/3
E 0/2 - 0/30 2/2
Twenty specific-pathogen-free Bama miniature pigs were randomly divided into five groups. Groups A, B and C (n = 5) were inoculated i.m. with 10
4,1 0
5 and 10
6
TCID50 CSFV Shimen strain, respectively. Three non-inoculated pigs were housed in the same pen and served as in-contact animals. Two uninfected control pigs
were housed in a separate pen. Clinical outcome, fever frequency and survival rates after viral challenge were calculated.
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Page 2 of 7of CSF, such as pinpoint haemorrhaging in the kidney
or haemorrhaging within the lymph nodes and urinary
bladder, necrosis in the tonsils, and splenic infarcts.
Such lesions are typical in larger domestic pigs infected
with CSFV. There were also obvious lesions in the liver
and lungs and the stomach showed large areas of hae-
morrhage and ulcers. Although no obvious clinical signs
were observed in the in-contact pigs, there was evidence
of specific CSF-induced pathological changes. The
scores for the pathological changes in each group are
shown in Table 3. Infected pigs also showed severe hae-
morrhaging within the stomach, intestinal tract and
mesentery. Surprisingly, the pathological changes
observed in the pigs challenged with 10
4 TCID50 were
more severe than those in the other pigs (data not
shown).
Samples were fixed in buffered formalin, embedded in
paraffin wax and stained with H&E for histopathological
examination. The most common histopathological find-
ings in the challenged and in-contact animals were mild
to severe lymphoid depletion, accompanied by hyperae-
mia and haemorrhage. Differing degrees of lymphoid
depletion were also observed in the spleen. Perivascular
cuffing, due to inflammatory lymphohistiocytic infil-
trates, was frequently observed in the liver and kidney.
The uninfected control animals showed no obvious
changes. A composite analysis using the histopathologi-
cal scoring system was performed, which yielded a mean
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Figure 1 Survival rates of pigs challenged with different doses of CSFV. Groups A, B and C (n = 5) were inoculated i.m. with 10
4,1 0
5 and
10
6 TCID50 CSFV Shimen strain, respectively. Three non-inoculated pigs were housed in the same pen and served as in-contact animals. Two
uninfected control pigs were housed in a separate pen.
Table 2 Detection of viral RNA in serum samples from
challenged pigs by real-time RT-PCR (copies/μL).
No. Days post-challenge
0 1 3 7 10 15
A1 - - 2.51 × 10
3 1.44 × 10
4 1.78 × 10
4 /
A2 - - 1.69 × 10
4 8.50 × 10
3 2.47 × 10
4 /
A3 - - 8.19 × 10
3 1.12 × 10
4 1.06 × 10
4 /
A4 - - 1.15 × 10
4 2.56 × 10
4 1.33 × 10
4 /
A5 - - 7.45 × 10
3 5.55 × 10
4 //
B1 - - 2.22 × 10
5 6.60 × 10
4 7.05 × 10
5 /
B2 - - 6.01 × 10
4 3.70 × 10
5 2.38 × 10
5 /
B3 - - 1.94 × 10
5 1.44 × 10
5 5.23 × 10
5 6.70 × 10
5
B4 - - 1.10 × 10
5 1.43 × 10
5 //
B5 - - 1.19 × 10
5 9.35 × 10
4 3.46 × 10
5 /
C1 - - 6.55 × 10
5 2.21 × 10
6 //
C2 - - 7.56 × 10
5 9.57 × 10
5 1.49 × 10
6 /
C3 - - 1.16 × 10
6 1.23 × 10
6 1.06 × 10
6 2.31 × 10
6
C4 - - 4.24 × 10
5 1.13 × 10
6 2.63 × 10
6 /
C5 - - 3.95 × 10
5 1.44 × 10
4 //
D1 - - 3.81 × 10
4 1.35 × 10
4 7.79 × 10
5 5.40 × 10
5
D2 - - 2.65 × 10
3 6.67 × 10
3 3.07 × 10
4 /
D3 - - 3.98 × 10
3 8.05 × 10
5 2.21 × 10
4 5.53 × 10
5
E 1 - - ----
E 2 - - ----
Serum samples were collected prior to inoculation and at 1, 3, 7, 10 and 15
dpi and tested for viral RNA using the real-time RT-PCR as described
previously (Zhao et al., 2008).
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Page 3 of 7histopathological score of 15.67 in group A, 15.4 in
group B, 17 in group C and 17.75 in group D (Table 4).
These data indicate that the histopathological changes
seen in the pigs in groups C and D were more severe
than those in groups A and B. No statistically significant
differences were observed between the challenged pigs
and the in-contact animals.
Discussion
This study was aimed to develop a Bama miniature pig
model of CSFV infection and to use this model to study
CSFV pathogenesis. The ultimate aim is to use the
model to evaluate new CSF vaccines. Developing alter-
native porcine models with different susceptibility to
CSFV would be highly beneficial, as it would help to
increase our knowledge of the molecular mechanisms
involved in resistance/susceptibility to the virus. This
may then, potentially, lead to breeding for enhanced
CSF-resistance using marker-assisted selection, an
important step toward disease control.
In this study, Bama miniature pigs were inoculated i.
m. with different doses of CSFV Shimen strain, which is
highly virulent in larger domestic pigs causing severe
CSF [13]. The results showed that Bama miniature pigs
are highly susceptible to CSFV, and infected pigs devel-
oped specific CSF clinical signs. These clinical signs
were mostly consistent with those observed in experi-
mentally infected domestic pigs. Marked CSF clinical
signs appeared 2 dpi and persisted until the end of the
trial. Like domestic pigs, the Bama miniature pigs
showed marked fever, with the peak temperature being
42°C. There were also specific clinical signs of CSF,
such as loss of appetite, lethargy, stiffness of gait and
oedema. Pronounced pathological changes were also
observed in the tissues and organs, including haemor-
rhaging in the kidney, lymph nodes and urinary bladder
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Figure 2 Log number of viral RNA copies from challenged pigs quantified using real-time RT-PCR (copies/μL). Heart, liver, spleen, lung,
kidney, stomach, urinary bladder, tonsils and lymph nodes were collected and the distributions of CSFV RNA determined.
Table 3 Average scores for the pathological changes observed in challenged Bama miniature pigs.
Groups Heart Liver Spleen Lung Kidney Stomach Bladder Lymph Nodes Tonsils Total
A 1.7 2.0 3.0 1.7 2.3 1.3 2.3 2.0 2.3 18.7
B 2.7 2.7 3.0 2.3 2.0 1.7 2.0 2.3 3.0 21.7
C 2.0 2.5 3.0 2.5 2.5 2.0 2.0 2.5 3.0 22.0
D 2.5 2.5 3.0 2.5 2.5 2.5 3.0 2.5 3.0 24.0
E 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Extended scoring systems for clinical symptoms and pathology were used allowing the detailed characterisation of the diseases and lesions (Everett et al., 2010).
Heart, liver, spleen, lung, kidney, stomach, bladder, tonsils and lymph nodes were collected from pigs that died from the infection or were euthanised at the end
of the trial. Examinations followed standard operational procedures and any observed lesions were recorded. A gross pathological scoring system was used
incorporating 10 parameters. Each parameter was scored from 0 (no lesion) to 3 (severe lesion).
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Page 4 of 7and necrosis in the tonsils and spleen, similar to that
observed in domestic pigs infected with CSFV [13].
Unexpectedly, more severe pathological changes, higher
fever frequency, and higher virus load were observed in
10
4 TCID50 group. The possible explanations may be: 1)
The infected animals were housed in the same room
and direct transmission between different dose groups
are likely to occur; 2) The three doses studied all exceed
the minimum lethal dose of the virus, thus dose effects
were not revealed; 3) The differences are not statistically
significantly different in most cases. To define the dose-
dependent pathogenicity,s m a l l e rd o s e ss h o u l db e
included in future study. Notably, the results of the
present study revealed obvious differences between
domestic pigs and Bama miniature pigs in terms of
pathological changes in the alimentary tract. Infected
miniature pigs showed severe haemorrhaging in the
digestive tract, including the stomach, intestinal tract
and mesentery, which are mild or absent in domestic
pigs. Possibly, there may be slight differences in tissue
tropism of CSFV between the two pig species, or just an
occasional case. A more detailed comparative pathology
study is needed to clarify the possible pathogenicity dif-
ferences. No obvious clinical signs of CSF were observed
in the in-contact pigs prior to death; although CSF-
induced pathological changes, consistent with those
observed in domestic pigs, were noted. These results
suggest that Bama miniature pigs are as susceptible to
CSFV as domestic pigs. More research regarding CSFV
replication, proliferation, pathogenesis and host interac-
tions (such as cytokine induction) are required, as acute
overproduction of some cytokines may play a key role
in pathogenesis [14].
Taking the temperature of Bama miniature pigs is very
difficult as they become agitated very easily. Therefore,
traditional methods (i.e., measuring rectal temperature)
are not suited to these animals. This means that the
recorded temperatures may not be very accurate. Thus,
a more simple and accurate method for taking the tem-
perature of these pigs, such as biochips, should be used.
The use of biochips for monitoring temperatures pro-
vides practical advantages in terms of easy monitoring,
which reduces disturbance to the animals and allows
more frequent measurement [15]. Also, it is very impor-
tant to take the temperature at consistent time points,
as these animals have a marked circadian rhythm [15].
Conclusions
Bama miniature pigs were infected with the highly viru-
lent CSFV Shimen strain and subsequent infection/
transmission was monitored establishing an experimen-
tal challenge model for CSFV. Further work is required
to establish whether this Bama miniature pig model can
be used to evaluate the efficacy of CSFV vaccines.
Materials and methods
Animals
Twenty 120-day-old SPF Bama miniature pigs (body
weight, 16-25 kg) were used in the study. All pigs were
clinically healthy and maintained in the animal facility at
Harbin Veterinary Research Institute under standard
conditions prescribed by the Institutional Guidelines.
The study protocol was approved by the Institutional
Animal Care and Use Committee. Each group (except
the control group) was placed in an individual pen in
the same room. Prior to the study, all pigs were negative
for CSFV antibodies and antigens as assessed by a CSFV
antibody detection kit (IDEXX, Liebefeld-bern, Switzer-
land) and a TaqMan real-time RT-PCR [16].
Virus
The highly virulent CSFV Shimen strain [17] was propa-
gated and titrated in PK-15 cells. Briefly, serial 10-fold
dilutions (10
-1 to 10
-10) of the virus stock were prepared
in Dulbecco’s modification of Eagle’sm e d i u m( D M E M )
and used to infect PK-15 cells (seeded in 96-well plates
on the previous day at a density of 10
6 cells/well). Each
dilution was assayed in duplicate (100 μl/well). Mock-
infections (cells not exposed to virus) were set up simul-
taneously. After 2 h of adsorption, the virus inoculum
was drawn off and DMEM containing 2% fetal bovine
serum (FBS) added. The cells were then incubated at
37°C in a humidified 5% CO2 incubator. On Day 3 post-
infection, the cells were washed twice with phosphate
buffered saline (PBS) and fixed for 8 min with cold
acetone. The fixed cells were then incubated with the
Table 4 Average scores for the histopathological changes observed in challenged Bama miniature pigs.
Groups Heart Liver Spleen Lung Kidney Stomach Bladder Lymph nodes Tonsils Total
A 0.33 1.83 2 2 1.83 0.67 2 2.67 2.33 15.67
B 0 1.8 2.8 2.4 1.2 1.2 1.2 2.4 2.4 15.4
C 0 1.6 2.8 2.4 2.4 0.8 1.8 3 2.2 17
D 1 2 2.75 1.75 2 1.75 1.75 2.5 2.25 17.75
E0 0 0 0 00 00 00
Samples were fixed in buffered formalin and embedded in paraffin wax. Sections were prepared and stained with H&E for histopathological examination.A
histopathological scoring system incorporating seven parameters was used and the severity of the lesions was scored from 0 (no lesion) to 3 (severe lesion).
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Page 5 of 7anti-E2 monoclonal antibody (mAb) HQ06 [18] for 1 h
at 37°C in a humidified chamber followed by three
washes with PBS. The cells were then incubated with
fluorescein isothiocyanate (FITC)-labelled goat anti-
mouse IgG (Sigma-Aldrich, Missouri, USA) for 45 min
at 37°C, followed by three washes with PBS. Finally, the
cells were covered with 90% alkaline glycerine and
examined under a fluorescence microscope (Nikon
TE200, Japan).
Animal inoculation
The pigs were randomly divided into five groups.
Groups A, B and C of five pigs each were housed in
three pens of one room and inoculated intramuscularly
(i.m.) with a 1-ml aliquot of CSFV Shimen strain at 10
4,
10
5 or 10
6 median tissue culture infective dose
(TCID50), respectively. Group D of three pigs were not
inoculated, but housed in the same room, serving as in-
contact infection controls. Group E comprised two
uninfected control animals housed in a pen of a separate
room. Standard disease parameters were determined as
described previously [15]. Following viral challenge, rec-
tal temperature and clinical signs (anorexia, depression,
shivering, haemorrhage, constipation and diarrhoea)
were recorded on a daily basis. The tonsils, spleen, kid-
ney, liver, lung, urinary bladder and lymph nodes were
harvested from the pigs after death (from infection or
after euthanasia at the end of the trial) were collected
for further immunohistochemical study and evaluation
of pathological changes.
Blocking ELISA
To monitor seroconversion, serum samples were col-
lected at 0, 3, 7, 10 and 15 dpi and tested for CSFV-spe-
cific antibodies using the IDEXX HerdChek* CSFV
Antibody Test Kit (IDEXX, Liebefeld-bern, Switzerland)
according to the manufacturer’s instructions.
Real-time RT-PCR
S e r u ms a m p l e sw e r ec o l l e c t e da t0 ,1 ,3 ,7 ,1 0a n d1 5
dpi to measure the level of viraemia. Tissues and organs
were also collected to determine the distribution of
CSFV RNA. CSFV RNA was isolated using an RNA iso-
lation kit (Qiagen, USA). CSFV RNA was quantified by
real-time RT-PCR using the TaqMan System, primers
and probes specific for CSFV, and an ABI 7700
Sequence Detector (PE Applied Biosystems, USA) as
described previously [16]. A standard curve was con-
structed using known amounts of RNA diluted in sal-
mon sperm RNA and used to determine the viral copy
number. The detection limit of the PCR assay was 41.8
RNA copies per reaction with excellent linearity (R >
0.94) over five logs of RNA content. The samples were
run in triplicates. For statistical purposes data were
expressed as the logarithm mean.
Pathology and histopathology
An extended pathological and histopathological scoring
system allowed detailed characterisation of pathological
lesions [15]. Heart, liver, spleen, lung, kidney, stomach,
urinary bladder, tonsils and lymph nodes were col-
lected for pathological examination. Examinations fol-
lowed standard operational procedures and any
observed lesions were recorded. The gross pathology
scoring system incorporated 10 parameters (body con-
dition, skin and subcutis, tonsils, spleen, kidney, ileum
and ileocecal valve, respiratory system, lymph nodes,
urinary bladder and conjunctiva). Each parameter was
scored from 0 (no lesion) to 3 (severe lesion). Samples
were fixed in buffered formalin and embedded in paraf-
fin wax. Sections (4 μm) were stained with haematoxy-
lin and eosin (H-E) for histopathological examination.
A histopathological scoring system incorporating seven
parameters (tonsils, spleen, lymph nodes, liver, lung,
kidney and ileocaecal valve) was also developed, and
the severity of the lesions scored from 0 (no lesion) to
3 (severe lesion). Data from both scoring systems were
analysed using the Kruskal-Wallis non-parametric
mean comparison test [19] and differences were con-
s i d e r e ds i g n i f i c a n ta tP < 0.05.
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